This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Chr Hansen-Novozymes deal receives antitrust clearance in Brazil

By Flavia Fortes ( October 3, 2023, 14:06 GMT | Insight) -- The Brazilian competition authority has cleared the merger between Danish enzyme makers Chr Hansen and Novozymes. The Administrative Council for Economic Defense, or CADE, considered the global market for food and beverage enzymes as the relevant market, but concluded that there are low barriers to entry and sufficient competition. The agency didn’t find that the vertical relationships created with the merged entity would lead to incentives to discriminate against rival enzyme makers and distributors. The Brazilian competition authority has cleared the merger between Danish enzyme makers Chr Hansen and Novozymes....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login